Wenzhuo Yang

656 citations
22 papers · 383 indexed · h-index 11
Topics
Liver Disease Diagnosis and Treatment (7 papers)MicroRNA in disease regulation (6 papers)Liver physiology and pathology (5 papers)

In The Last Decade

Wenzhuo Yang

20 papers receiving 379 citations

Peers

Wenzhuo Yang
Comparison fields: 5 of 78
  • Molecular Biology 152
  • Cancer Research 123
  • Epidemiology 94
  • Artificial Intelligence 60
  • Hepatology 48
Replace Hanning Wang with:
Hanning Wang China
Shi Zhou China
Keyan Wu China
Salima Akter South Korea
Juliette Joubert‐Zakeyh France
Zita Soons Netherlands
Linlin Wei China
Tianqi Xu China
Wenzhuo Yang relative to Hanning Wang China Hanning Wang's profile →
Citations per field
00.5×1.7×
Hanning Wang · 1×
Citations per year

Countries citing papers authored by Wenzhuo Yang

Since Specialization
Citations

This map shows the geographic impact of Wenzhuo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenzhuo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenzhuo Yang more than expected).

Fields of papers citing papers by Wenzhuo Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenzhuo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenzhuo Yang. The network helps show where Wenzhuo Yang may publish in the future.

Co-authorship network of co-authors of Wenzhuo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenzhuo Yang. A scholar is included among the top collaborators of Wenzhuo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenzhuo Yang. Wenzhuo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 6
4 25
5 5
6 21
7 4
8 19
9 69
10 2
11 3
12 2
13 33
14 18
15 30
16 19
17 57
18 8
19
[Mechanism of hepatic stellate cell migration during liver fibrosis].
8
20
[Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis].
21

About Wenzhuo Yang

Wenzhuo Yang is a scholar working on Hepatology, Aging and Cancer Research, having authored 22 papers that have together received 383 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), MicroRNA in disease regulation (6 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Cancer Research (123 citations), Hepatology (48 citations) and Epidemiology (94 citations). Wenzhuo Yang has collaborated with scholars based in China, North Macedonia and Singapore. Frequent co-authors include Jingqi Liu, Changqing Yang, Jiale Guo, Jun Zhao, Ziyao Liu, Kwok‐Yan Lam, Yang Song, Meiyi Song, Yanning Yang and Xiaoyu Chen. Their work appears in journals such as Life Sciences, Digestive Diseases and Sciences and Journal of Cellular and Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026